THRESA SIMON: Open Payments
NPI 1003871989 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 20 payments from 5 companies in 2025. Trend: 2023 $213 · 2024 $193 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $278 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: COBENFY, Auvelity, UZEDY, REXULTI, AUSTEDO XR, Qelbree.
Industry payments across VA — which companies pay providers there.
